FDA Approves LAMOTRIGINE — Aurobindo Pharma Limited
Aurobindo Pharma Limited secured final FDA approval for its generic Lamotrigine oral tablets, a development anticipated to enhance the company's market share in the anticonvulsant segment and facilitate additional revenue growth.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day